Cadila Healthcare News

Markets

Cadila Healthcare’s earnings, covid-19 portfolio drive stock

Given that the company stock is up about 72% in 2020, a good chunk of likely growth is already factored in

1 min read3 Nov 2020
News

Zydus Cadila gets tentative nod from USFDA to market diabetes drug

Linagliptin tablets are used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetesShares of Cadila Healthcare were trading 0.88% lower at ₹414.75 apiece on BSE

1 min read29 Oct 2020
Companies

Zydus Cadila gets USFDA nod for muscle relaxant injection

Cadila Healthcare says Zydus Cadila has received final approval from the USFDA to market Cisatracurium Besylate Injection USP in the strength of 20 mg (base)/10 mL (2 mg/mL) multiple-dose vial

1 min read2 Sep 2020
Companies

Cadila Healthcare June quarter net profit up 50% at ₹454 cr

Consolidated revenue from operations of the company stood at ₹3,639.9 crore for the quarter under consideration, as against ₹3,496.3 crore for the same period year ago

1 min read5 Aug 2020
Markets

Investors to wait and watch as Cadila starts covid vaccine trials

There are several global players rushing to develop a vaccine, and some of them could get the nod much earlierSome analysts think that there may not be much pricing power in covid vaccines if the launch takes time

1 min read20 Jul 2020
Companies

Cadila Health shares rise after its covid vaccine gets DCGI nod for human trials

Shares of the pharmaceuticals company rose by as much as 4.61% on Friday The vaccine developed by Cadila Healthcare was found to elicit a strong immune response in multiple animal species

1 min read3 Jul 2020
Industry

Zydus Cadila gets tentative nod from USFDA for Parkinson's treatment capsule

The approval by the US Food and Drug Administration is for Carbidopa and Levodopa extended-release capsules in the strengths of 23.75 mg/95 mg, 36.25 mg/145 mg, 48.75 mg/195 mg, and 61.25 mg/245 mg, Cadila Healthcare said in a regulatory filing.

1 min read30 Mar 2020
Markets

Drug approvals perk up Cadila Healthcare, potential is priced in

Firm also received a warning letter for Moraiya plant in Ahmedabad, which puts at risk about 30 new drug applicationsCadila Healthcare received about 175 new product approvals in the past three years, which has improved revenue prospects in the US market

1 min read8 Mar 2020
Markets

Stocks to Watch: Maruti Suzuki, Bharti Airtel, Cadila Healthcare, NBFCs, MTNL

Maruti Suzuki signed a MoU with Federal Bank Ltd for dealer and retail car financingPSU Bank stocks will be in focus as RBI Governor told heads of banks that resolution of stressed assets should happen in a co-ordinated manner

3 min read12 Dec 2019
Companies

Cadila Healthcare acquires remaining stake in 2 subsidiaries for $250,000

While Cadila Healthcare is spending $225,000 for Zydus Technologies, it will buy the stake in Zydus Noveltech for $25,000The company expects the acquisition to complete within a month, as per a filing with exchanges

1 min read13 Nov 2019
Load More

Popular Topics

Budget

The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared

25 Articles

Plain Facts

Exciting, sharp and clear analysis of the trends that matter, through data and charts. Plain Facts is published every weekday, with coverage spanning across themes, including corporate strategy to inflation to unemployment and emerging sectors. Follow us on #MintPlainFacts across social media.

11 Articles